ArticleJournal for immunotherapy of cancer2020

Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

Samanta Romina Zanetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.